A Transcriptomic Classifier Model Identifies High-Risk Endotypes in a Prospective Study of Sepsis in Uganda
In high-income countries (HICs), sepsis endotypes defined by distinct pathobiological mechanisms, mortality risks, and responses to corticosteroid treatment have been identified using blood transcriptomics. The generalizability of these endotypes to low-income and middle-income countries (LMICs), wh...
Saved in:
| Published in: | Critical care medicine Vol. 52; no. 3; p. 475 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.03.2024
|
| Subjects: | |
| ISSN: | 1530-0293, 1530-0293 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | In high-income countries (HICs), sepsis endotypes defined by distinct pathobiological mechanisms, mortality risks, and responses to corticosteroid treatment have been identified using blood transcriptomics. The generalizability of these endotypes to low-income and middle-income countries (LMICs), where the global sepsis burden is concentrated, is unknown. We sought to determine the prevalence, prognostic relevance, and immunopathological features of HIC-derived transcriptomic sepsis endotypes in sub-Saharan Africa.
Prospective cohort study.
Public referral hospital in Uganda.
Adults ( n = 128) hospitalized with suspected sepsis.
None.
Using whole-blood RNA sequencing data, we applied 19-gene and 7-gene classifiers derived and validated in HICs (SepstratifieR) to assign patients to one of three sepsis response signatures (SRS). The 19-gene classifier assigned 30 (23.4%), 92 (71.9%), and 6 (4.7%) patients to SRS-1, SRS-2, and SRS-3, respectively, the latter of which is designed to capture individuals transcriptionally closest to health. SRS-1 was defined biologically by proinflammatory innate immune activation and suppressed natural killer-cell, T-cell, and B-cell immunity, whereas SRS-2 was characterized by dampened innate immune activation, preserved lymphocyte immunity, and suppressed transcriptional responses to corticosteroids. Patients assigned to SRS-1 were predominantly (80.0% [24/30]) persons living with HIV with advanced immunosuppression and frequent tuberculosis. Mortality at 30-days differed significantly by endotype and was highest (48.1%) in SRS-1. Agreement between 19-gene and 7-gene SRS assignments was poor (Cohen's kappa 0.11). Patient stratification was suboptimal using the 7-gene classifier with 15.1% (8/53) of individuals assigned to SRS-3 deceased at 30-days.
Sepsis endotypes derived in HICs share biological and clinical features with those identified in sub-Saharan Africa, with major differences in host-pathogen profiles. Our findings highlight the importance of context-specific sepsis endotyping, the generalizability of conserved biological signatures of critical illness across disparate settings, and opportunities to develop more pathobiologically informed sepsis treatment strategies in LMICs. |
|---|---|
| AbstractList | In high-income countries (HICs), sepsis endotypes defined by distinct pathobiological mechanisms, mortality risks, and responses to corticosteroid treatment have been identified using blood transcriptomics. The generalizability of these endotypes to low-income and middle-income countries (LMICs), where the global sepsis burden is concentrated, is unknown. We sought to determine the prevalence, prognostic relevance, and immunopathological features of HIC-derived transcriptomic sepsis endotypes in sub-Saharan Africa.
Prospective cohort study.
Public referral hospital in Uganda.
Adults ( n = 128) hospitalized with suspected sepsis.
None.
Using whole-blood RNA sequencing data, we applied 19-gene and 7-gene classifiers derived and validated in HICs (SepstratifieR) to assign patients to one of three sepsis response signatures (SRS). The 19-gene classifier assigned 30 (23.4%), 92 (71.9%), and 6 (4.7%) patients to SRS-1, SRS-2, and SRS-3, respectively, the latter of which is designed to capture individuals transcriptionally closest to health. SRS-1 was defined biologically by proinflammatory innate immune activation and suppressed natural killer-cell, T-cell, and B-cell immunity, whereas SRS-2 was characterized by dampened innate immune activation, preserved lymphocyte immunity, and suppressed transcriptional responses to corticosteroids. Patients assigned to SRS-1 were predominantly (80.0% [24/30]) persons living with HIV with advanced immunosuppression and frequent tuberculosis. Mortality at 30-days differed significantly by endotype and was highest (48.1%) in SRS-1. Agreement between 19-gene and 7-gene SRS assignments was poor (Cohen's kappa 0.11). Patient stratification was suboptimal using the 7-gene classifier with 15.1% (8/53) of individuals assigned to SRS-3 deceased at 30-days.
Sepsis endotypes derived in HICs share biological and clinical features with those identified in sub-Saharan Africa, with major differences in host-pathogen profiles. Our findings highlight the importance of context-specific sepsis endotyping, the generalizability of conserved biological signatures of critical illness across disparate settings, and opportunities to develop more pathobiologically informed sepsis treatment strategies in LMICs. In high-income countries (HICs), sepsis endotypes defined by distinct pathobiological mechanisms, mortality risks, and responses to corticosteroid treatment have been identified using blood transcriptomics. The generalizability of these endotypes to low-income and middle-income countries (LMICs), where the global sepsis burden is concentrated, is unknown. We sought to determine the prevalence, prognostic relevance, and immunopathological features of HIC-derived transcriptomic sepsis endotypes in sub-Saharan Africa.OBJECTIVESIn high-income countries (HICs), sepsis endotypes defined by distinct pathobiological mechanisms, mortality risks, and responses to corticosteroid treatment have been identified using blood transcriptomics. The generalizability of these endotypes to low-income and middle-income countries (LMICs), where the global sepsis burden is concentrated, is unknown. We sought to determine the prevalence, prognostic relevance, and immunopathological features of HIC-derived transcriptomic sepsis endotypes in sub-Saharan Africa.Prospective cohort study.DESIGNProspective cohort study.Public referral hospital in Uganda.SETTINGPublic referral hospital in Uganda.Adults ( n = 128) hospitalized with suspected sepsis.PATIENTSAdults ( n = 128) hospitalized with suspected sepsis.None.INTERVENTIONSNone.Using whole-blood RNA sequencing data, we applied 19-gene and 7-gene classifiers derived and validated in HICs (SepstratifieR) to assign patients to one of three sepsis response signatures (SRS). The 19-gene classifier assigned 30 (23.4%), 92 (71.9%), and 6 (4.7%) patients to SRS-1, SRS-2, and SRS-3, respectively, the latter of which is designed to capture individuals transcriptionally closest to health. SRS-1 was defined biologically by proinflammatory innate immune activation and suppressed natural killer-cell, T-cell, and B-cell immunity, whereas SRS-2 was characterized by dampened innate immune activation, preserved lymphocyte immunity, and suppressed transcriptional responses to corticosteroids. Patients assigned to SRS-1 were predominantly (80.0% [24/30]) persons living with HIV with advanced immunosuppression and frequent tuberculosis. Mortality at 30-days differed significantly by endotype and was highest (48.1%) in SRS-1. Agreement between 19-gene and 7-gene SRS assignments was poor (Cohen's kappa 0.11). Patient stratification was suboptimal using the 7-gene classifier with 15.1% (8/53) of individuals assigned to SRS-3 deceased at 30-days.MEASUREMENTS AND MAIN RESULTSUsing whole-blood RNA sequencing data, we applied 19-gene and 7-gene classifiers derived and validated in HICs (SepstratifieR) to assign patients to one of three sepsis response signatures (SRS). The 19-gene classifier assigned 30 (23.4%), 92 (71.9%), and 6 (4.7%) patients to SRS-1, SRS-2, and SRS-3, respectively, the latter of which is designed to capture individuals transcriptionally closest to health. SRS-1 was defined biologically by proinflammatory innate immune activation and suppressed natural killer-cell, T-cell, and B-cell immunity, whereas SRS-2 was characterized by dampened innate immune activation, preserved lymphocyte immunity, and suppressed transcriptional responses to corticosteroids. Patients assigned to SRS-1 were predominantly (80.0% [24/30]) persons living with HIV with advanced immunosuppression and frequent tuberculosis. Mortality at 30-days differed significantly by endotype and was highest (48.1%) in SRS-1. Agreement between 19-gene and 7-gene SRS assignments was poor (Cohen's kappa 0.11). Patient stratification was suboptimal using the 7-gene classifier with 15.1% (8/53) of individuals assigned to SRS-3 deceased at 30-days.Sepsis endotypes derived in HICs share biological and clinical features with those identified in sub-Saharan Africa, with major differences in host-pathogen profiles. Our findings highlight the importance of context-specific sepsis endotyping, the generalizability of conserved biological signatures of critical illness across disparate settings, and opportunities to develop more pathobiologically informed sepsis treatment strategies in LMICs.CONCLUSIONSSepsis endotypes derived in HICs share biological and clinical features with those identified in sub-Saharan Africa, with major differences in host-pathogen profiles. Our findings highlight the importance of context-specific sepsis endotyping, the generalizability of conserved biological signatures of critical illness across disparate settings, and opportunities to develop more pathobiologically informed sepsis treatment strategies in LMICs. |
| Author | Jain, Komal Lipkin, W Ian Tomoiaga, Alin S Owor, Nicholas Byaruhanga, Timothy Sameroff, Stephen Che, Xiaoyu Namulondo, Joyce Nsereko, Christopher Cummings, Matthew J Muwanga, Moses Kayiwa, John Price, Adam O'Donnell, Max R Nayiga, Irene Kyebambe, Stephen Lutwama, Julius J Bakamutumaho, Barnabas |
| Author_xml | – sequence: 1 givenname: Matthew J surname: Cummings fullname: Cummings, Matthew J organization: Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY – sequence: 2 givenname: Barnabas surname: Bakamutumaho fullname: Bakamutumaho, Barnabas organization: Immunizable Diseases Unit, Uganda Virus Research Institute, Entebbe, Uganda – sequence: 3 givenname: Alin S surname: Tomoiaga fullname: Tomoiaga, Alin S organization: Department of Accounting, Business Analytics, Computer Information Systems, and Law, Manhattan College, New York, NY – sequence: 4 givenname: Nicholas surname: Owor fullname: Owor, Nicholas organization: Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda – sequence: 5 givenname: Komal surname: Jain fullname: Jain, Komal organization: Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY – sequence: 6 givenname: Adam surname: Price fullname: Price, Adam organization: Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY – sequence: 7 givenname: John surname: Kayiwa fullname: Kayiwa, John organization: Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda – sequence: 8 givenname: Joyce surname: Namulondo fullname: Namulondo, Joyce organization: Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda – sequence: 9 givenname: Timothy surname: Byaruhanga fullname: Byaruhanga, Timothy organization: Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda – sequence: 10 givenname: Moses surname: Muwanga fullname: Muwanga, Moses organization: Entebbe General Referral Hospital, Ministry of Health, Entebbe, Uganda – sequence: 11 givenname: Christopher surname: Nsereko fullname: Nsereko, Christopher organization: Entebbe General Referral Hospital, Ministry of Health, Entebbe, Uganda – sequence: 12 givenname: Irene surname: Nayiga fullname: Nayiga, Irene organization: Entebbe General Referral Hospital, Ministry of Health, Entebbe, Uganda – sequence: 13 givenname: Stephen surname: Kyebambe fullname: Kyebambe, Stephen organization: Entebbe General Referral Hospital, Ministry of Health, Entebbe, Uganda – sequence: 14 givenname: Stephen surname: Sameroff fullname: Sameroff, Stephen organization: Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY – sequence: 15 givenname: Xiaoyu surname: Che fullname: Che, Xiaoyu organization: Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY – sequence: 16 givenname: Julius J surname: Lutwama fullname: Lutwama, Julius J organization: Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda – sequence: 17 givenname: W Ian surname: Lipkin fullname: Lipkin, W Ian organization: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY – sequence: 18 givenname: Max R surname: O'Donnell fullname: O'Donnell, Max R organization: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37548511$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtLw0AcxBep2Id-A5E9ekndV17HEqottCi2nsNm9791bZKN2UTot7dqhc5lhuHHHGaMBrWrAaFbSqaUpPFDlq2n5EwRYfwCjWjISUBYygdneYjG3n8QQkUY8ys05HEokpDSEdrP8LaVtVetbTpXWYWzUnpvjYUWr52GEi811N1P4fHC7t6DV-v3eF5r1x2aY2drLPFL63wDqrNfgDddrw_YGbyBxttf4G0nay2v0aWRpYebk0_Q9nG-zRbB6vlpmc1WgRJhwoOURYWKNKSaRUlsWASKEyDMSCOMSQpJCU_TQpBUQQoF01wnIhKCasYo02yC7v9mm9Z99uC7vLJeQVnKGlzvc5aImAsak_CI3p3QvqhA501rK9ke8v9_2Des3Wom |
| CitedBy_id | crossref_primary_10_3389_fendo_2024_1452993 crossref_primary_10_1016_j_jointm_2025_03_004 crossref_primary_10_1164_rccm_202311_2086SO crossref_primary_10_1371_journal_pgph_0004429 crossref_primary_10_3389_fimmu_2025_1546474 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/CCM.0000000000006023 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1530-0293 |
| ExternalDocumentID | 37548511 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Uganda |
| GeographicLocations_xml | – name: Uganda |
| GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR001873 – fundername: FIC NIH HHS grantid: D43 TW009607 – fundername: NIAID NIH HHS grantid: K23 AI163364 – fundername: Medical Research Council grantid: MC_UU_00033/1 – fundername: Wellcome Trust grantid: 107743 |
| GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 1J1 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6J9 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPPZ ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY AE6 AEBDS AENEX AFBFQ AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 E.X EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B N9A NPM N~7 N~B O9- OAG OAH OB4 OBH ODMTH ODZKP OHH OHYEH OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PONUX RIG RLZ S4R S4S TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM YFH YOC YOJ ZFV ZY1 ~9M 7X8 ADKSD ADSXY |
| ID | FETCH-LOGICAL-c4583-926bc6de9d2687f26ec30e02faf4ff8ba10399b409ce9eb2d3d846441d2212d2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001168124200003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1530-0293 |
| IngestDate | Thu Oct 02 11:35:31 EDT 2025 Sat May 31 02:13:46 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4583-926bc6de9d2687f26ec30e02faf4ff8ba10399b409ce9eb2d3d846441d2212d2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pmc.ncbi.nlm.nih.gov/articles/PMC10847381/pdf/nihms-1919462.pdf |
| PMID | 37548511 |
| PQID | 2847341705 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2847341705 pubmed_primary_37548511 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-March |
| PublicationDateYYYYMMDD | 2024-03-01 |
| PublicationDate_xml | – month: 03 year: 2024 text: 2024-March |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Critical care medicine |
| PublicationTitleAlternate | Crit Care Med |
| PublicationYear | 2024 |
| SSID | ssj0014573 |
| Score | 2.477064 |
| Snippet | In high-income countries (HICs), sepsis endotypes defined by distinct pathobiological mechanisms, mortality risks, and responses to corticosteroid treatment... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 475 |
| SubjectTerms | Adrenal Cortex Hormones Adult Gene Expression Profiling Humans Prospective Studies Sepsis Transcriptome Uganda - epidemiology |
| Title | A Transcriptomic Classifier Model Identifies High-Risk Endotypes in a Prospective Study of Sepsis in Uganda |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37548511 https://www.proquest.com/docview/2847341705 |
| Volume | 52 |
| WOSCitedRecordID | wos001168124200003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC6dLt57klKsXiwpWiV3kqyDwmVpDYq-O-d2ST0JAjmkENIIOzOznyz38x-hNzoINUwmwlTnmeYL7sB-EGdMqs54nOACK7L9eUhGo3i6VSO6w23si6rbHyic9S6ULhH3kE3Ch434sHt4p2hahSyq7WExjppeQBl0Kqj6YpF8APHMMOi5oxDXGta52TU6feH1dGF9RVyFCz6DWS6YDPY_e9v7pGdGmbSXmUX-2TN5Adka1gT6Ydk3qMuSjmfgY3J1KljZhaiJEV9tDdatfDCg5JiMQh7zMo5vcshi4XUtaRZThM6XhZNqybFisRvWlj6ZBZl5l54fsV9iiMyGdxN-ves1l1gCllUJkWYqlAbqUUYR1aERnnccGET61sbpwnSxzKFzFAZCZm59jSgGMBVWkAg1OKYbORFbk4J1Tw1fhjKQBnrR1bFFkKhDwjImK5JhN8m180ozsCskatIclN8lrPVOLbJSTUVs0V1_sYMVXsRKJ794etzsi0AhlRVYxekZWFRm0uyqb4-snJ55ewF7qPx8AfTJMlK |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Transcriptomic+Classifier+Model+Identifies+High-Risk+Endotypes+in+a+Prospective+Study+of+Sepsis+in+Uganda&rft.jtitle=Critical+care+medicine&rft.au=Cummings%2C+Matthew+J&rft.au=Bakamutumaho%2C+Barnabas&rft.au=Tomoiaga%2C+Alin+S&rft.au=Owor%2C+Nicholas&rft.date=2024-03-01&rft.eissn=1530-0293&rft.volume=52&rft.issue=3&rft.spage=475&rft_id=info:doi/10.1097%2FCCM.0000000000006023&rft_id=info%3Apmid%2F37548511&rft_id=info%3Apmid%2F37548511&rft.externalDocID=37548511 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-0293&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-0293&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-0293&client=summon |